Fig. 2.
Total Symptom Score percentage change from baseline to week 24 by patient subgroup. Dashed lines represent the mean percentage change from baseline for overall treatment group (Verstovsek et al, 2012). ECOG PS, Eastern Cooperative Oncology Group performance status; Hb, haemoglobin; Int-2, Intermediate-2; IPSS, International Prognostic Scoring System; MF, myelofibrosis; PET, post-essential thrombocythaemia; PMF, primary myelofibrosis; PPV, post-polycythaemia vera; SEM, standard error of the mean.
